Therefore, together these findings first support the fact that in certain TNBCs when TET1 is high, immune response genes are low, and in other basal-like breast cancers, TET1 is low possibly because of immune system modulating the cancer cell epigenetics. Here, TET1 is linked to breast carcinoma.